Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.